Stock APLLTD ALEMBIC PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News Alembic Pharmaceuticals Limited

Equities

APLLTD

INE901L01018

Market Closed - NSE India S.E.
Other stock markets
 07:43:46 2024-04-26 am EDT 		5-day change 1st Jan Change
990.2 INR -0.73% Intraday chart for Alembic Pharmaceuticals Limited +5.53% +30.40%
Apr. 08 Alembic Pharmaceuticals Limited Received 3 Assessment Orders from the Office of Assistant Commissioner (ST), Andhra Pradesh CI
Apr. 02 Alembic Pharmaceuticals Appoints Manish Kejriwal as Independent Director CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Alembic Pharmaceuticals Board to Consider Dividend for Fiscal 2024; Shares Drop 3%
MT
Alembic Pharmaceuticals Limited Received 3 Assessment Orders from the Office of Assistant Commissioner (ST), Andhra Pradesh
CI
Alembic Pharmaceuticals Appoints Manish Kejriwal as Independent Director
CI
Alembic Pharmaceuticals Gets US FDA Tentative Nod for Generic Breast Cancer Treatment
MT
Alembic Pharmaceuticals Limited Receives One US Food & Drug Administration Product Approval
CI
Alembic Pharmaceuticals Limited Announces Board Cessations
CI
Alembic Pharmaceuticals Limited Receives Order from Commission of Customs, Mumbai Zone- III
CI
Alembic Pharmaceuticals' Oncology Plant in Gujarat, India Gets One Observation from US FDA
MT
Alembic Pharmaceuticals Limited Announces United States Food and Drug Administration Conducted an Inspection At Oncology Formulation Facility At Panelav
CI
Crisil Keeps AA+ Rating on Alembic Pharmaceuticals' Bank Loans with Stable Outlook
MT
Indian shares seen muted tracking broader Asian equities
RE
Alembic Pharmaceuticals Fully Resumes Operations at Manufacturing Unit in South Sikkim, India
MT
Alembic Pharmaceuticals' Consolidated Net Profit Jumps in Fiscal Q3; EPS Tops Estimates
MT
Alembic Pharmaceuticals' Consolidated Profit Climbs in Fiscal Q3, EPS Beats Estimates
MT
Transcript : Alembic Pharmaceuticals Limited, Q3 2024 Earnings Call, Feb 05, 2024
India's Alembic Pharma beats Q3 profit view on strong domestic, US sales
RE
Alembic Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
Alembic Pharmaceuticals Limited Announces Designation of Manuj Desai as Head - It as Senior Management Personnel
CI
Alembic Pharmaceuticals Expects Operations at Sikkim, India Units to Be Restores in Two Months
MT
Alembic Pharmaceuticals Extends Corporate Guarantee to US-Based Arm to Secure Credit
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. APLLTD Stock
  4. News Alembic Pharmaceuticals Limited